Search Legislation

The Human Tissue (Quality and Safety for Human Application) (Amendment) Regulations 2018

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening Options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendment of Part 1 of the Principal Regulations

This section has no associated Explanatory Memorandum

2.—(1) In regulation 2(3) of the Principal Regulations (extent and application), for “import and export”, substitute “import into the United Kingdom and export from the United Kingdom”.

(2) In regulation 3 of the Principal Regulations (designation of the competent authority), for “the first, second and third Directives”, substitute “the first, second, third and fourth Directives”.

(3) Regulation 4 of the Principal Regulations (references to Directives) is amended as follows—

(a)at the end of the definition of “the third Directive”, insert “as amended by Commission Directive 2015/565/EU(1),”; and

(b)after the definition of “the third Directive”, insert—

“the fourth Directive” means Commission Directive 2015/566 of 8th April 2015 implementing Directive 2004/23/EC as regards the procedures for verifying the equivalent standards of quality and safety of imported tissues and cells..

(4) Regulation 5 of the Principal Regulations (interpretation of other terms) is amended as follows—

(a)in paragraph (1)—

(i)at the appropriate place, insert—

“a case of emergency” means any unforeseen situation in which there is no practical alternative other than to urgently import into the United Kingdom from a third country or to export from the United Kingdom to a third country tissues or cells for immediate application to a known recipient whose health would otherwise be seriously endangered;;

“distribution” in relation to tissues or cells intended for human application means transportation or delivery to any person in or outside the United Kingdom for human application, and related terms are to be interpreted accordingly;;

“importing licence holder” means a licence holder who is authorised by that licence to import tissues or cells intended for human application into the United Kingdom from a third country;;

“third country” means a country which is not an EEA state or Gibraltar;;

“third country premises” means premises—

(a)

in a third country; and

(b)

on, or from which, a third country supplier, or a person providing services to a third country supplier, procures, tests, processes, stores, distributes or exports tissues or cells that are intended for import into the United Kingdom for human application;;

“third country supplier” means a person in a third country who has an agreement with an importing licencing holder for exporting tissues or cells intended for import into the United Kingdom for human application;; and

(ii)omit the definitions of “export” and “import”;

(b)in paragraph (2), for “and Article 2 of the third Directive (definitions)”, substitute “, Article 2 of the third Directive and Article 2 of the fourth Directive (definitions)”;

(c)in paragraph (4)—

(i)for sub-paragraph (a), substitute—

(a)a person who, from any premises, controls the provision of services for transporting or delivering tissues or cells to any person in or outside the United Kingdom for human application is to be taken to distribute tissues or cells on those premises; and; and

(ii)in sub-paragraph (b) for “or third” substitute “, third or fourth”.

(5) Regulation 6 of the Principal Regulations (references to third party agreements etc) is amended as follows—

(a)in paragraph (1)(a), for “(other than storage)”, substitute “(other than storage or import into the United Kingdom from a third country)”; and

(b)in paragraph (2), in the definition of “relevant third party premises”, in sub-paragraph (a)—

(i)omit “or to which a third party imports”; and

(ii)after “exports”, insert “from the United Kingdom to a third country”.

(1)

OJEU L093, 09.04.2015, p43.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Impact Assessments

Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:

  • Why the government is proposing to intervene;
  • The main options the government is considering, and which one is preferred;
  • How and to what extent new policies may impact on them; and,
  • The estimated costs and benefits of proposed measures.
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources